Etrolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameEtrolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade
SourceCAS 1044758-60-2
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsEtrolizumab,Anti-Beta7,PRO145223,RG7413,rhuMAb Beta7,ITGA4_ITGB7,anti-ITGA4_ITGB7
ReferencePX-TA1255
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Etrolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade

General information on Anti-ITGA4_ITGB7[Homo sapiens] (Etrolizumab) Monoclonal Antibody

Etrolizumab has investigated for the treatment of Crohn Disease and Ulcerative Colitis.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Etrolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

ITGA4 recombinant protein
Antigen

ITGA4 recombinant protein

PX-P5178 385€
Stable Isotope Labelled Etrolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade
SIL

Stable Isotope Labelled Etrolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade

PX-TA1255-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products